Search citation statements
Paper Sections
Citation Types
Year Published
Publication Types
Relationship
Authors
Journals
The manuscript aims to provide glimpse on updated information relating thermo-mechanical dry coating processes (TMDCP) suiting in modifying surface attributes of fine and ultra-fine particle (FiUlFiP). FiUlFiPs are the integral component of pharmaceutical processes. They exhibit complex and queer properties, are conferred mostly from their surface attributes colligated with their higher surface area. Particle engineering technocrats extensively working for modifying surface & surface attributes of FiUlFiPs. These efforts are to find their worthy applications & new functionalities. Among available diverse particle engineering technologies/ process, TMDCP, a dry coating process (DCP), advocated being worthy and efficient. The TMDCP finds multidisciplinary applications, mostly in drug development & drug delivery. Said DCP involves fixing and/or attaching coating material (CoM) as particles herein synonym guest particle (GP) onto core/substrate particle (CSP) herein synonym host particle (HP). Attaching/ fixing the GPs onto HPs, in TMDCP, involve their mechanical and/or thermal interactions. Scientific literatures are evidencing diverse techniques and/or process, basing on discussed interactions. Amongst them novel techniques/ processes are Hybridization, Magnetically assisted impaction coating process (MAICP), Mechanofusion, Theta-composer, and high shear compaction. In this area diverse devices/ equipments are prevailing in market. Important are Hybridizer, Magnetically assisted impaction coater (MAIC), Theta-composer, Mechanofusion, Quadro Comil®, Cyclomix®, and many others. Attempt of this article is to discuss and present their method of working, working principle, applicability, limitations, and benefits. Contained information might be beneficial for professionals of pharmaceutical and allied field. Keywords: dry coating, equipment, particles, processes, thermo-mechanical.
The manuscript aims to provide glimpse on updated information relating thermo-mechanical dry coating processes (TMDCP) suiting in modifying surface attributes of fine and ultra-fine particle (FiUlFiP). FiUlFiPs are the integral component of pharmaceutical processes. They exhibit complex and queer properties, are conferred mostly from their surface attributes colligated with their higher surface area. Particle engineering technocrats extensively working for modifying surface & surface attributes of FiUlFiPs. These efforts are to find their worthy applications & new functionalities. Among available diverse particle engineering technologies/ process, TMDCP, a dry coating process (DCP), advocated being worthy and efficient. The TMDCP finds multidisciplinary applications, mostly in drug development & drug delivery. Said DCP involves fixing and/or attaching coating material (CoM) as particles herein synonym guest particle (GP) onto core/substrate particle (CSP) herein synonym host particle (HP). Attaching/ fixing the GPs onto HPs, in TMDCP, involve their mechanical and/or thermal interactions. Scientific literatures are evidencing diverse techniques and/or process, basing on discussed interactions. Amongst them novel techniques/ processes are Hybridization, Magnetically assisted impaction coating process (MAICP), Mechanofusion, Theta-composer, and high shear compaction. In this area diverse devices/ equipments are prevailing in market. Important are Hybridizer, Magnetically assisted impaction coater (MAIC), Theta-composer, Mechanofusion, Quadro Comil®, Cyclomix®, and many others. Attempt of this article is to discuss and present their method of working, working principle, applicability, limitations, and benefits. Contained information might be beneficial for professionals of pharmaceutical and allied field. Keywords: dry coating, equipment, particles, processes, thermo-mechanical.
Manuscript aims to furnish glimpse on coating processes (CoPr). The coating is the process of applying coating materials (CoMa) onto the substrate surface (S-S). With time and space dimension of CoPr, that upraised as sugarcoating (S-C) expanded to film-coating (F-C) and specialized one. Lengthy and wearisome processing and skilled operators issues inherited to S-C spring-up F-C and its improvement from non-aqueous F-C to aqueous film-coating (AF-C). Nonaqueous film-coating processes (F-CP) make use of a volatile organic solvent (VOS) while AF-C processes uses aqueous solvent (AS), as a solvent system for coating formulations (C-F). VOS is preferred over AS in F-CP, and momentum for using AS has been accelerating from past few decades. Issues from VOS"s use upraised relating to safety; worker hygiene & safety; toxicity; environmental pollution; etc. These upraised issues intensified, thus, nowadays, AF-C processes are replacing VOS-based F-CP. Later on, finding the novelty of coating and CoPr thru coating of particulates became another dimension of expansion. This involves modification and/or alteration in innate properties of particulates, chemically and/or physically, thru coating, is for find their worthy attributes and functionalities. This dimensional expansion exploits the applicability of the dry-coating process (D-CP) and wetcoating process (W-CP). D-CP comprises novel and specialized CoPr based on novel technologies while W-CP comprises conventional and novel CoPr. Some state-of-art CoPr are AF-C process, hot-melt coating (H-MC) process, electrical-electrostatic deposition process, gas-/vapor-phase process, aerosolized CoPr, photo-curable CoPr, Resonant acoustic CoPr, thermal and mechanical process, thermo-mechanical CoPr, fluidized-bed processes, Supercell ® CoPr, etc. CoPr and its dimensional expansion briefed for updating professionals.INTRODUCTION: Solid dosage forms comprise a major fraction of pharmaceutical products, and their formulation ingredients, in most instances, are in particulate state 1-6 . In some instances of manufacturing processes, inevitable is a coating of themselves or component particulates [7][8][9][10][11] . Coating of solid dosage form or their component particulates involves deposition of CoMa, as a layer, snugly affixes on surface of said substrates [9][10][11] .
This manuscript aims to figure out updated information on the dry coating of powder (DCP). In pharmaceutical processes, the inevitable is handling of fine and ultra-fine particles (FUFP). Their higher surface area associated surface and surface attributes contribute chiefly to exhibited complex phenomenon like bulk behaviors, physicochemical property, performances and functionalities of pharmaceutical importance, and many others. Nowadays particle engineering techniques are extensively exploited to modify surface and surface attributes of FUFP to find their worthy applications and new functionalities. Among available diverse techniques for particle engineering DCP is advocated as a worthy and efficient one. The DCP is considered to have multidisciplinary applications in drug development and drug delivery. Process basis of DCP calls for attaching and/or fixing the particles of coating material (PCM) or guest particle (GuP) onto the substrate/core particle (S/CP) or host particle (HoP). Fixing/ attaching the PCM onto HoPs mandates their interaction that may be mechanical, chemical, thermal, electro-chemical and many others. Scientific literature and patents are evidencing diverse processes and methods for interacting S/CPs or HoPs with PCM or GuPs. Amongst them, novel methods are Magnetically Assisted Impaction Coating (MAIC), Hybridizer®, Mechanofusion®, Theta Composer®, Electrostatic Dry Coating (EDC), Atomic/ Molecular Layer Deposition (ALMD), Chemical Vapor Deposition (CVD). Principle and method of working, applicability, limitations, and benefits of novel DCP process and methods are discussed and presented in this article. It"s hope; that contained information will benefit pharmaceutical and allied field professionals.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.